Severe life-threatening parasitic liver disease complicated by dissemination to the lungs
Robert Rosoľanka Orcid.org 1, Daniela Antolová2, Elena Nováková3, Veronika Bartošová1
+ Affiliation
Summary
Alveococcosis is a life threatening tissue parasitosis caused by the larvae of Echinococcus multilocularis, also termed taenia. It results in helminthozoonosis, a parasitosis in which the parasite is transmitted from animals to humans, and where humans act as the accidental hosts. The primary location of the parasite is in the liver, but in rare cases, th is can lead to secondary dissemination and the formation of a secondary form of alveococcosis, which most commonly occurs in the lungs and brain. In this case report, we present a case of a 21-year-old patient with alveolar echinococcosis of the liver, complicated by secondary formation of pulmonary lesions. We emphasize the need for a thorough examination of the lungs and the CNS using imaging methods in patients suspected of suffering from alveococcosis.
Keywords
Echinococcus multilocularis, alveolar echinococcosis of the liver, pulmonary echinococcosisTo read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Vaništa J. Echinokokóza (hydatidóza) cystická. In: Beneš J et al (ed). Infekční lekárství. Praha: Galén 2009: 359– 360.
2. Eckhert J, Schantz PM, Gasser RB et al. Geographic distribution and prevalence. In: Eckert J (eds). WHO/ OIE manual on echinococcosis in humans and animals: a public health problem of global concern. Paris: WHO 2001: 100– 142.
3. Antolová D, Miterpáková M, Škútová M et al. Echinococcus multilocularis na Slovensku – aktuálna situácia. Infovet 2015;
21(6): 245– 249.
4. Eckhert J, Deplazes P. Biological, epidemiological,and clinical aspects of echinococcosis,a zoonosis of increasing
concern. Clin Microbiol Rev 2004; 17(1): 107– 135.
5. Antolová D, Meterpáková M, Radoňák J et al Alveolar echinococcosis in a highly endemic area of northern Slovakia between 2000 and 2013. Eurosurveillance 2014; 19(34); 20882.
6. Kinčeková J, Dubinský P, Dvorožňáková E et al. Diagnostika a výskyt alveolárnej echinokózy na Slovensku. Ces Slov Gastroent Hepatol 2005; 59(1): 11– 16.
7. Vaništa J. Klinický obraz a léčení alveokokózy.Epidemiol Mikrobiol Imunol 1997; 46(4): 166– 167.
8. Szilágyiová M, Michal L, Škračiková J. Výskyt črevných parazitov u detí a dospelých osôb pred odchodom a po návrate zo zahraničia. Slovenský lekár 1992; 2(6– 7): 16– 20.
9. Šimeková K, Hudečková H. Malária importovaná do Slovenskej republiky zo stredoafrickej republiky. Interná med 2006;
6(1): 25– 27.
10. Šimeková K, Vestenická G, Hudečková H. Ďalší prípad tropickej malárie importovanej do SR. Interná med 2008; 8(7– 8): 417– 418.
11. Svihrová V, Szilagyiová M, Krkoska D et al. Analysis of the direct and indirect costs of treatment of imported malaria in
the Slovak Republic. Rev Soc Bras Med Trop 2009; 42(4): 377– 380.
12. Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 2010, 23(5): 505– 512.
doi: 10.1097/ QCO.0b013e32833d7 516.
13. Kinčeková J, Hrčková G, Auer H et al. Clinical and serological study of human alveolar echinococcosis in Slovakia
in relation to the outcome of chemotherapy. Helmithologia 2006; 43(4): 213– 219. doi: 10.2478/ s11687-006-00 40-y.
14. Vuitton DA, Bresson- Hadni S. Alveolar echinococcosis: evaluation of therapeutic strategies. Expert Opinion on Orphan Drugs 2014; 2(1): 67– 86.
15. Koch S, Bresson-Hadni S, Miguet JP et al. Experience of liver transplantation for incurable alveolar echinococcosis:
a 45-case European collaborative report. Transplantation 2003; 75(6): 856– 863.
16. Laca L, Olejnik J, Vician M et al. The effects of occlusive techniques on the short-term prognosis after liver resections.
HepatoGastroenterology 2006; 53(70): 576– 579.
17. Godot V, Harraga S, Podoprigora G et al. IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology 2003, 124(5): 1441– 1450.